Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Lazaro Gamio/Axios

For 5 years, Elon Musk has been warning about apocalyptic runaway AI, calling it more dangerous than nukes. To stave off his feared future, in 2016 he launched Neuralink, a company to create cyborgs with the express mission of getting ahead of superhuman intelligence.

What's happening: Now, Musk says he has charted the long path to merging man and machine. In an elaborate presentation Tuesday night, he said his company has installed brain–computer links in rats and monkeys and aims to put them inside human skulls next year.

The big picture: Around the world, top research labs are building brain–computer interfaces (BCIs), devices that can both read brain activity directly from neurons and write information straight into the brain.

  • At this early stage, BCIs are being used to treat conditions and injuries related to the brain or nervous system, including Parkinson's disease or paralysis, allowing people to control, and even feel, prosthetic limbs with their minds.
  • In the far future, researchers want to implant interfaces into healthy people. Among their ideas is to use the implants for communication, or a super-efficient connection to an electronic device.

But for Musk, medical uses are a stepping stone to an existential imperative.

  • Last year, he told Axios on HBO that Neuralink's ultimate goal is to "achieve a long-term symbiosis with artificial intelligence."
  • BCI, he says, is the best defense against an alarming future in which AI suddenly surpasses human intelligence and leaves our species behind — or totally imperiled.

Key quote: "This has a very good purpose, which is to cure important diseases — and ultimately to secure humanity's future as a civilization relative to AI," Musk said Tuesday night at the California Academy of Sciences in San Francisco.

Many AI researchers, who still struggle to get computers and robots to complete some basic tasks, disagree with Musk's techno-doomsaying. But Musk has called them "fools."

How it works: Neuralink's system consists of hundreds of electrodes implanted deep inside the brain, connected by tiny wires to a hub that communicates wirelessly with a device behind the wearer's ear. There's also a robotic "sewing machine" that plunges the electrodes into patients' brains.

  • A version of the device has been tested on rats, according to an unreviewed white paper Neuralink circulated after Tuesday's event.
  • And in response to a question on stage, Musk casually dropped that it's also been installed on a monkey, which used it to control a computer. The next step is human testing, which Neuralink hopes to get underway next year.

Reality check: Getting surgical implants into healthy humans is a long shot in the near future, says Kenneth Shepard, a BCI researcher at Columbia University.

  • For the Food and Drug Administration to approve an implant, the upsides have to far outweigh the risks. "And anything that requires surgical implantation comes with a lot of risk," says Shepard.
  • Much more likely to be approved are medical applications that address sensory or motor problems like blindness or paralysis — a significant benefit to outweigh the risks of poking stuff into brains.
  • And those are still out of reach of the best scientists, who are developing devices and software to reliably decode brain activity and send signals back into the mind.

Asked Tuesday how he plans to construct a viable business, Musk said simply that the economics of curing brain diseases and injuries "will easily pay for itself."

  • In the long run, Musk joked, "I think it's safe to say you could repay the loan with superhuman intelligence."

Go deeper: A device to translate brain activity into speech

Go deeper

House passes $1.9 trillion COVID relief package

Photo: Screenshot via C-SPAN

The House approved President Biden's $1.9 trillion COVID relief package on a 219-212 vote early Saturday morning, sending it to the Senate for a possible rewrite before it gets to Biden's desk.

The big picture: The vote was a critical first step for the package, which includes $1,400 cash payments for many Americans, a national vaccination program, ramped-up COVID testing and contact tracing, state and local funding and money to help schools reopen.

7 hours ago - Health

Biden says it's "not the time to relax" after touring vaccination site

President Biden speaking after visiting a FEMA Covid-19 vaccination facility in Houston on Feb. 26. Photo: Mandel Ngan/AFP via Getty Images

President Biden said Friday that "it's not the time to relax" coronavirus mitigation efforts and warned that the number of cases and hospitalizations could rise again as new variants of the virus emerge.

Why it matters: Biden, who made the remarks after touring a vaccination site in Houston, echoed CDC director Rochelle Walensky, who said earlier on Friday that while the U.S. has seen a recent drop in cases and hospitalizations, "these declines follow the highest peak we have experienced in the pandemic."

Updated 8 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Health: Most COVID-19 survivors can weather risk of reinfection, study says — "Twindemic" averted as flu reports plummet amid coronavirus crisis
  2. Vaccine: FDA advisory panel endorses J&J COVID vaccine for emergency use — About 20% of U.S. adults have received first vaccine dose, White House says — New data reignites the debate over coronavirus vaccine strategy.
  3. Economy: What's really going on with the labor market.
  4. Local: All adult Minnesotans will likely be eligible for COVID-19 vaccine by summer — Another wealthy Florida community receives special access to COVID-19 vaccine.
  5. Sports: Poll weighs impact of athlete vaccination.